<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63865">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02041637</url>
  </required_header>
  <id_info>
    <org_study_id>AOM11030</org_study_id>
    <nct_id>NCT02041637</nct_id>
  </id_info>
  <brief_title>Unknown Cause of Acute Liver Failure</brief_title>
  <acronym>HASIPRO</acronym>
  <official_title>Unknown Cause of Acute Liver Failure: Determination of Early Mortality Predictive Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the outcome and to determine predictive factors of
      patients admitted in a context of acute liver failure without identified cause.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methodology: Multicentric French national cohort with prospective collection of data and
      constitution of biobank, in patients hospitalized in a context of acute liver failure
      without known cause at admission. Follow-up during 3 months for each patients. The primary
      objective is to determine predictive factors of early mortality. This study is an
      observational cohort and patients will received standard care during the follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>At 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Liver transplantation rate</measure>
    <time_frame>At 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival rate</measure>
    <time_frame>At 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-transplant mortality rate</measure>
    <time_frame>At 3 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Liver Failure</condition>
  <condition>Unknown Etiology</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Acute liver failure without cause identified at admission
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute liver failure defined by a PT&lt;50% or INR&gt;1.5;

          -  with or without hepatic encephalopathy;

          -  without cause identified at admission, and non A non B hepatitis;

          -  age&gt;18 year old;

          -  signed an informed consent.

        Exclusion Criteria:

          -  chronic liver disease;
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Audrey COILLY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP-HP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier Samuel, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>AP-HP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Audrey COILLY, MD</last_name>
    <phone>+ 33 (1) 45 59 33 36</phone>
    <email>audreycoilly@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire</name>
      <address>
        <city>Villejuif</city>
        <zip>94800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey COILLY, MD</last_name>
      <phone>+33 (1) 45 21 31 21</phone>
      <email>audreycoilly@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>January 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver failure</keyword>
  <keyword>etiology</keyword>
  <keyword>liver transplantation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Liver Failure, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
